HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Sunscreen use

This article was originally published in The Rose Sheet

Executive Summary

Sunscreen use: Skin Cancer Foundation emphasizes the use of sunscreens as "an integral part of a comprehensive program" to prevent melanoma in a statement released Feb. 20. Responding to a Memorial Sloan-Kettering Cancer Center study reported at the American Association for the Advancement of Science annual meeting, the Foundation said "suntanning and sunburning both result from genetic damage at the cellular DNA level, and should in no way be considered helpful in skin cancer prevention....Sunscreen is one of the strategy that helps prevent this damage." The study researcher had questioned claims that sunscreens aid in the prevention of skin cancer, proclaiming the "blanket advice" to wear sunscreens is "not warranted" ("The Rose Sheet" Feb. 23, p. 23)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel